TLDR
- Vertiv shares declined 3.1% to close at $241.91 Friday, touching an intraday bottom of $238.65 with trading volume 33% above typical levels
- Analysts continue showing optimism — RBC increased price target to $266, Mizuho to $290, and Roth MKM to $275
- Fourth-quarter results exceeded projections: $1.36 EPS versus $1.29 forecast, with revenues climbing 22.7% annually
- Company insiders divested approximately 412,467 shares totaling around $104.4M in the last three months
- Directors declared a $0.0625 quarterly dividend per Class A share, distributed March 26
Vertiv (VRT) shares experienced a 3.1% decline Friday, finishing the session at $241.91 after touching a session low of $238.65. The previous day’s closing price stood at $249.75.
Trading activity revealed notable patterns. Approximately 8.07 million shares were exchanged — representing a 33% increase compared to the typical daily volume of about 6.05 million. Such heightened activity during a decline often indicates genuine distribution rather than routine volatility.
The downturn occurred even as Vertiv’s board declared a quarterly cash distribution of $0.0625 per Class A share. Shareholders recorded by March 17 will receive payment on March 26.
Such dividend announcements typically demonstrate management’s optimism about cash flow sustainability. The company’s year-to-date gains remain strong at 54.16%, suggesting Friday’s retreat follows substantial appreciation.
From a fundamental perspective, the numbers look solid. Vertiv unveiled Q4 results on February 11, delivering $1.36 in earnings per share — surpassing the $1.29 analyst consensus by $0.07.
Quarterly revenues reached $2.88 billion, marginally below the $2.89 billion projection, yet representing 22.7% growth versus the prior-year period. The year-ago EPS figure of $0.99 highlights meaningful progression.
Looking forward, Vertiv provided Q1 2026 EPS guidance ranging from $0.950 to $1.010, with full-year 2026 guidance between $5.970 and $6.070. The Street currently projects $3.59 EPS for the ongoing fiscal year.
Wall Street Maintains Elevated Price Objectives
Analyst sentiment remained undeterred. After February’s earnings disclosure, Mizuho elevated its price objective from $198 to $290 with an “outperform” designation. Royal Bank of Canada adjusted its target upward from $200 to $266, maintaining “outperform.” Roth MKM confirmed a “buy” rating with a $275 objective.
Weiss Ratings enhanced VRT from “hold” to “buy” status on February 13. The exception was Wolfe Research, which downgraded from “outperform” to “peer perform” in December.
According to MarketBeat intelligence, the consensus includes 1 strong buy, 19 buy, 2 hold, and 1 sell recommendation — yielding a “Moderate Buy” consensus with an average price objective of $230.28.
Executive Share Sales Draw Attention
The pattern of insider transactions warrants scrutiny. During the previous 90-day window, company insiders liquidated 412,467 shares worth approximately $104.4 million.
Director Roger Fradin disposed of 101,666 shares on February 27 at an average price of $252.13, generating proceeds exceeding $25.6 million. EVP Anders Karlborg sold 30,487 shares on February 26 at $246.92 — reducing his position by 46.74%.
Company insiders currently maintain 2.63% ownership, while institutional stakeholders control 89.92%.
The equity trades with a market capitalization of $92.55 billion, a price-to-earnings multiple of 70.94, and a beta coefficient of 2.02. The 50-day moving average registers at $201.78, with the 200-day average at $174.70. Current pricing exceeds both benchmarks substantially.
As of Friday’s close, technical indicators continue generating a “buy” signal.





